Síndrome de Guillain-Barre


Página 1 Página 2 Página 3 Página 4 Página 5 Página 6 Página 7 Página 8 Página 9

Si te resulta de interés, comparte en tu red social:

Hartung HP, Kieseier BC, Hughes RAC. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10(9):643-651

11- Wu J, Xu F, Lu L, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med. 2010;363(25):2416-2423.PubMed

12- Grimaldi-Bensouda L, Alpérovitch A, Besson G, et al; GBS-PGRx Study Group. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol. 2011;174(3):326-335

13- Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M.VAESCO-GBS Case-Control Study Group. Guillain-Barre syndrome and adjuvanted pandemic influenza A(H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011;343d3908

PubMeddoi: 10.1136/bmj.d3908.

14- Plasmaferesis en el Sindrome de Guillain Barré. 23 de noviembre de 2012] Disponible en: http://redalyc.uaemex.mx/src/inicio/ArtPdfRed.jsp? iCve=211117850013 [PDF]

15- Inicio de un síndrome de GuillainBarré durante la gestación. Mas, M.M.; Morán, E.; Mariño, M. Publicado en Clin Invest Ginecol Obstet. 2012;39:210-2. – vol.39 … www.elsevier.es

16- From the Department of Medicine, National University of Singapore, Singapore (N.Y.); and the Department of Neurology, Heinrich Heine University, Düsseldorf, Germany (H.-P.H.).Address reprint requests to Dr. Yuki at the Department of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine, 14 Medical Dr., Singapore 117599, Singapore, or at yuki.research@gmail.com.

17- GuillainBarré Syndrome — American Academy of Neurology.


Guideline: IVIg Effective for Certain Nerve and Muscle Disorders, 03.26.2012. Study: GuillainBarré Syndrome Cases Low After 2009 H1N1 Vaccine, 04.13.2010 …

18- IntraMed – Artículos – Síndrome de GuillainBarré.www.intramed.net/76411.02/07/2012 – N Engl J Med 2012;366:2294-304.

19- Familial GuillainBarré syndrome: First Indian report Naik KR, Saroja …www.annalsofian.org/article.asp?…2012;…Ann Indian Acad Neurol [serial online] 2012 [cited 2013 Feb 10];15:44-7.

20- GuillainBarré Syndrome — NEJM

www.nejm.org/doi/full/10…/NEJMc1208413 .GuillainBarré Syndrome. N Engl J Med 2012; 367:973-974September 6, 2012DOI: 10.1056/NEJMc1208413. Share: Article …

21- Síndrome de GuillainBarré. Asociación con antagonista de FNTa

revistamedica.imss.gob.mx/index.php?.Artículos relacionados. 2012-10-15 – Síndrome de GuillainBarré. Asociación con antagonista de FNTa. Rev Med Inst Mex Seguro Soc 2012; 50 (5): 565-567 …

22- Adams RD, Victor M, Ropper AH. Principles of neurology. 6thed. New York: Mc Graw, 1997. p. 1312-1318.

23- Mishu B, Blazer MJ. Role of infection due to compylobacter jejuni in the inhibition of Guillan Barre syndrome. Clin Infect Dis 1993;17:104-108.

24- Mishu B, Blaser MJ. Campylobacter jejuni human immunodeficiency virus and Guillan Barre syndrome (letter). J Infect Dis 1994;115(3):1169-77.

25- Shigenazy K. Campylobacter jejuni shemis from patients with Guillan Barre syndrome belong serogroup 19 and contein B-N-Acetyl glucosamine residues. Ann Neurol 1993;33:243-247.

26- Aspinall GO. Hypopolisacharides of compylobacter jejuni serotype 0-19 structure of care oligosacharide regims from the serostrain and two bacterial isolates from patients with the Guillan Barre syndrome. Biochemistry 1994;33(1):241-49.

27- Asbury AK, Arnason BGW, Adam RD. The inflammatory lesion in acute idiopathic polineuritis. Medicine 1969;48:173.

28- Ropper AH. The CNS in Guillan Barre syndrome. Arch Neurol 1983;40:397-398.

29- Haymaker W, Kernehan JW. The landey Guillain Barre syndrome. Clinoco pathologic report of fifty fatal cases and critique of the literature. Medicine 1949;28:59.

30- Ropper AH. Visual clinical variants and signs in Guillan Barre syndrome. Arch Neurol 1988;45:635.

31- Ropper AH. The Guillain Barre syndrome. New Eng J Med 1992;326:1130-1136.

32- Asbury AK, Cornblath DR. Assessment of current diagnostic criteria of Guillain Barre syndrome. ANN Neurol 1990;27:521-24.

33- Honovar M, Thanavan JK, Hughes RAC. A clinicopathological study of Guillain Barre syndrome. Nine cases and literature review. Brain 1991;114:1245.

34- Enders V, Karch, Toyka KV, Michels M. The spectrum of immune response to campylobacter jejuni and glycoconjugates in Guillain Barre syndrome and other neuroimmunological disorders. Ann Neurol 1993;34136-144.

35- Hartung HP. Immunopathogenesis and treatment of the Guillain Barre syndrome. Muscle Nerve 1995;18(2):137.153.

36- Gilburd B. Autoantibodies to phospholipids and brain extract in patients with Guillain Barre syndrome cross-reactive or pathogenic? Autoimmunity 1993;16(1):22-27.

37- Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplejia, atoce andareflexia). New Eng J Med 1956;225:57-65.

38- Griffin JW, Yi CY, Ho TW. Guillain Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577.

39- McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z. Acute motor axonal neuropathy. A frecuent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.

40- Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Han AF, Koopman WF. An acute axonal form of Guillain Barre polyneuropathy. Brain 1986;109:1115-26.

41- Ropper AH, Kehne SM. Guillain Barre syndrome management of respiratory failure. Neurology 1985;35:1662.

42- French Cooperative Group. Efficiency of plasma exchange in Guillain Barre syndrome. Ann Neurol 1987;22:753.

43- Guillain Barre study group. Plasmaferesis and acute Guillain Barre syndrome. Neurology 1985;35:1056.

44- Dick JJ. A plasma exchange versus immunoglubulin infusion tonal in chronic inflammatory desmielinating poliradiculoneuropathy. Ann Neurol 1984;36(6):838-845.

45- McKhann GM, Griffin JW, Cornblath DR. Plasmapheresis and Guillain Barre syndrome. Analysis of prognostic factors and the effect of plasmapheresis. Ann Neurology 1988;23:347.

46- Pritchard J.Novel Therapeutic approaches to Guillen

Página 1 Página 2 Página 3 Página 4 Página 5 Página 6 Página 7 Página 8 Página 9

(1, 1)

Pages: 1 2 3 4 5 6 7 8 9

Si te resulta de interés, comparte en tu red social:

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

Otros temas de interés:close